DEPLOYDatabase

Company

Virtual Incision

Virtual Incision is a surgical robotics company developing MIRA, a miniaturized robot-assisted surgery (miniRAS) platform designed to make every operating room…

HQ
Lincoln, Nebraska, USA
Status
active

The verified answer

As of Aug 2026, DEPLOY verifies Virtual Incision: 1 model. 1 source back the record.

Regulatory status1 FDA De Novo authorization

Virtual Incision holds 1 FDA De Novo authorization, per the DEPLOY registry.

See all 1 filings

CategorySurgical robots

Overview

Virtual Incision is a surgical robotics company developing MIRA, a miniaturized robot-assisted surgery (miniRAS) platform designed to make every operating room robot-ready. The company raised $46M in a Series C round led by Endeavour Vision and Baird Capital, with an additional $30M extension. CEO Jim Alecxih leads the company in pursuing FDA clearance for its MIRA platform for laparoscopic procedures.

Verified record

Verified deployments
None on file
Active incidents
None on file

Key facts

Robot

MIRA, a miniaturized in-vivo robotic-assisted surgery platform with a single arm that mounts directly to the operating table without a large base console

Focus

Expanding access to robotic surgery for ambulatory surgery centers

Scale

A MIRA unit was tested aboard the International Space Station

Country

United States

Product

MIRA miniaturized robot-assisted surgery (miniRAS)

Data & sources

Web sources

1

1 source backing this record.View all →

Current leadership (2)

Founders (2)

See all founders across the registry →

Former / Previously (1)

Safety record

No incidents on record for Virtual Incision.

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Full safety record: incidents, sourcing, and exposure data →

Recent coverage

Virtual Incision in third-party press

Peer companies